SCHEMBL17859148

SCHEMBL17859148

CCc1ccc(N(CC(C)C)S(=O)(=O)c2ccc(NC[C@@H]3[C@H]4COC[C@@H]34)c([N+](=O)[O-])c2)cc1

nearest known ligand 0.61

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
RORC P51449 20/20 0.61
IL17A Q16552 4/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20677639 1.00 RORC (0.61) RORCIL17A
SCHEMBL17843892 0.91 RORC (0.73) RORCIL17A
SCHEMBL17843840 0.87 RORC (0.76) RORCIL17A
SCHEMBL20677625 0.87 RORC (0.64) RORCIL17A
SCHEMBL17859192 0.87 RORC (0.64) RORCIL17A
SCHEMBL20262142 0.85 RORC (0.84) RORCIL17A
SCHEMBL20684098 0.85 RORC (0.84) RORCIL17A
SCHEMBL20262143 0.85 RORC (0.84) RORCIL17A
SCHEMBL17860848 0.85 RORC (0.84) RORCIL17A
SCHEMBL17843868 0.84 RORC (0.56) RORCIL17A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233838-B1 BENZIMIDAZOLE SULFONAMIDE DERIVATIVES AS INVERSE AGONISTS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA (ROR GAMMA (T)) GALDERMA RES & DEV (FR) 2019-01-30 EP disclosed
WO-2016097393-A1 BENZIMIDAZOLE SULFONAMIDE DERIVATIVES AS INVERSE AGONISTS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA (ROR GAMMA (T)) GALDERMA RESEARCH & DEVELOPMENT (FR) 2016-06-23 WO disclosed